• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双嘧达莫可在人体内诱导产生干扰素。

Dipyridamole induces interferon in man.

作者信息

Galabov A S, Mastikova M

出版信息

Biomed Pharmacother. 1984;38(8):412-3.

PMID:6084526
Abstract

Thirty-six out of 40 healthy volunteers responded with a markedly elevated blood interferon (IFN) content to a single oral administration of dipyridamole (a 100 mg dose): 958.0 +/- 23.5 IU/ml serum at the 24th-48th hour. A hyporeactivity state to the repeated inducer application was found within the time interval of 4th-6th day. It was established that 7/8 of the dipyridamole-induced IFN represented IFN-alpha.

摘要

40名健康志愿者中,有36人在单次口服双嘧达莫(100毫克剂量)后,血液干扰素(IFN)含量显著升高:在第24至48小时时血清中为958.0 +/- 23.5国际单位/毫升。在第4至6天的时间间隔内发现对重复诱导剂应用存在低反应性状态。已确定双嘧达莫诱导的IFN中7/8为IFN-α。

相似文献

1
Dipyridamole induces interferon in man.双嘧达莫可在人体内诱导产生干扰素。
Biomed Pharmacother. 1984;38(8):412-3.
2
Interferon-inducing activity of dipyridamole in mice.双嘧达莫在小鼠体内的干扰素诱导活性。
Acta Virol. 1983 Jul;27(4):356-8.
3
Dipyridamole is an interferon inducer.双嘧达莫是一种干扰素诱导剂。
Acta Virol. 1982 May;26(3):137-47.
4
[Blood levels of opioid peptides and alpha interferon under the action of dipyridamole].[双嘧达莫作用下阿片肽和α干扰素的血药浓度]
Biull Eksp Biol Med. 1990 May;109(5):462-4.
5
Dipyridamole-induced interferon production in mouse peritoneal leukocytes.双嘧达莫诱导小鼠腹腔白细胞产生干扰素。
Biochem Int. 1985 Oct;11(4):591-8.
6
Lack of interferon production by dipyridamole.双嘧达莫不产生干扰素。
J Interferon Res. 1988 Apr;8(2):135-6. doi: 10.1089/jir.1988.8.135.
7
[Bropirimine (U-54461S) phase I clinical studies].[溴匹立明(U-54461S)一期临床研究]
Gan To Kagaku Ryoho. 1996 Dec;23(14):1941-9.
8
A method to assess the immunomodulating effects of the Tołpa Torf Preparation (TTP) by measuring the hyporeactivity to interferon induction and tumor necrosis factor response.
Arch Immunol Ther Exp (Warsz). 1993;41(1):87-93.
9
[Time course of interferon status of patients with herpetic keratitis during treatment with actipol, a new inteferon inducer].
Vestn Oftalmol. 2001 Jan-Feb;117(1):33-6.
10
Clinical pharmacokinetics of 5-fluorouracil. Influence of the biomodulating agents interferon, dipyridamole and folinic acid alone and in combination.5-氟尿嘧啶的临床药代动力学。生物调节剂干扰素、双嘧达莫和亚叶酸单独及联合使用的影响。
Arzneimittelforschung. 1993 Mar;43(3):387-90.

引用本文的文献

1
Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients.双嘧达莫在 COVID-19 患者中的潜在治疗益处。
Curr Pharm Des. 2021;27(6):866-875. doi: 10.2174/1381612826666201001125604.
2
Non-Classical Effects of the cAMP Accumulation Activators .环磷酸腺苷(cAMP)积累激活剂的非经典效应
Adv Pharm Bull. 2020 Jul;10(3):477-481. doi: 10.34172/apb.2020.059. Epub 2020 May 11.
3
COVID-19-associated coagulopathy: An exploration of mechanisms.COVID-19 相关凝血功能障碍:机制探索。
Vasc Med. 2020 Oct;25(5):471-478. doi: 10.1177/1358863X20932640. Epub 2020 Jun 19.
4
New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm.新型(再)用途的老药:嘌呤能调节可能扑灭 COVID-19 的血栓炎症风暴。
JCI Insight. 2020 Jul 23;5(14):140971. doi: 10.1172/jci.insight.140971.
5
Dipyridamole, as an interferon inducer, versus placebo in the prevention of recurrences of condylomata acuminata after diathermocoagulation.双嘧达莫作为一种干扰素诱导剂,与安慰剂相比,用于预防电凝治疗后尖锐湿疣的复发。
Genitourin Med. 1995 Feb;71(1):57-8. doi: 10.1136/sti.71.1.57-a.